M L 11 (Levothyroxine 150 mcg (0.15 mg))
Pill imprint M L 11 has been identified as Levothyroxine sodium 150 mcg (0.15 mg).
Levothyroxine is used in the treatment of hashimoto's disease; hypothyroidism, after thyroid removal; underactive thyroid; tsh suppression; thyroid suppression test (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 150 mcg (0.15 mg) is not a controlled substance under the Controlled Substance Act (CSA).
- M L 11
- 150 mcg (0.15 mg)
- 9.00 mm
- Prescription only
- Drug Class:
- Thyroid drugs
- Pregnancy Category:
- A - Studies show no risk
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- butylated hydroxyanisole
sodium lauryl sulfate
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|51079-0445||UDL Laboratories Inc|
|54569-5655||A-S Medication Solutions, LLC (repackager)|
|49999-0796||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about levothyroxine
- Levothyroxine capsules
- Levothyroxine solution
- Levothyroxine (Advanced Reading)
- Levothyroxine Injection (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.